Biolife Solutions Inc (BLFS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: April 13, 2018
Pages: 30
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: BBF7F3B6B70EN
Leaflet:

Download PDF Leaflet

Biolife Solutions Inc (BLFS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

BioLife Solutions Inc (BioLife Solutions) is a provider of biopreservation media products for cells, tissues, and organs. The company offers products such as cryostor, hypothermosol, bloodstor, and cell thawing media. It provides amniotic epithelial cells, avulsed teeth, blood vessels, bone marrow, caco-2, cancer stem cells, cord blood stem cells, cornea, corneal epithelial cells, dental pulp stem cells, dermal papilla cells, endometrial repair cells, endothelial cells, HEK, islet cells, and others. BioLife Solutions also offers liver tissue, lymphocytes, MDCK, neuronal cells, pancreatic tissue, placental stem cells, progenitor cells, red blood cells, renal cells, skeletal myoblasts, and smooth muscle cells, among others. The company performs custom formulation, fill, and finish services for direct, distributor, and contract customers. It offers its products for regenerative medicine, biobanking, and drug discovery markets. BioLife Solutions is headquartered in Bothell, Washington, the US.

Biolife Solutions Inc (BLFS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Biolife Solutions Inc, Medical Devices Deals, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deal Details
Private Equity
Casdin Capital to Invest in BioLife Solutions
Partnerships
Biolife Solutions Forms Joint Venture with SAVSU
BioLife Solutions Enters Into Distribution Agreement With Savsu Technologies
Licensing Agreements
BioLife Solutions Enters Into Licensing Agreement With Janssen Research & Development For CryoStor
Equity Offering
BioLife Solutions Raises USD1.9 Million in Private Placement of Shares upon Exercise of Warrants
Biolife Solutions Completes Public Offering Of Units For US$15.4 Million
Biolife Solutions Inc - Key Competitors
Biolife Solutions Inc - Key Employees
Biolife Solutions Inc - Locations And Subsidiaries
Head Office
Recent Developments
Financial Announcements
Apr 02, 2018: BioLife Solutions Announces Preliminary First Quarter 2018 Revenue of $3.8 Million, up 61% Year-over-Year and 22% Sequentially
Mar 08, 2018: BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results
Jan 04, 2018: BioLife Solutions Announces Preliminary 2017 Revenue Increase of 34% to $11 Million
Nov 09, 2017: BioLife Solutions Announces Third Quarter 2017 Financial Results
Aug 10, 2017: BioLife Solutions Announces Second Quarter 2017 Financial Results
May 11, 2017: BioLife Solutions Announces Q1 2017 Financial Results
Mar 09, 2017: BioLife Solutions Reports 4th Quarter and Full Year 2016 Results
Jan 12, 2017: BioLife Solutions Announces 2016 Revenue Growth of 28%
Other Significant Developments
Jul 05, 2017: BioLife Solutions Modifies Existing Credit Facility
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Biolife Solutions Inc, Pharmaceuticals & Healthcare, Key Facts, 2016
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Biolife Solutions Inc, Medical Devices Deals, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
Casdin Capital to Invest in BioLife Solutions
Biolife Solutions Forms Joint Venture with SAVSU
BioLife Solutions Enters Into Distribution Agreement With Savsu Technologies
BioLife Solutions Enters Into Licensing Agreement With Janssen Research & Development For CryoStor
BioLife Solutions Raises USD1.9 Million in Private Placement of Shares upon Exercise of Warrants
Biolife Solutions Completes Public Offering Of Units For US$15.4 Million
Biolife Solutions Inc, Key Competitors
Biolife Solutions Inc, Key Employees

LIST OF FIGURES

Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Biolife Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Biolife Solutions Inc, Medical Devices Deals, 2012 to YTD 2018
Skip to top


Ask Your Question

Biolife Solutions Inc (BLFS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: